Retinal nerve fibre layer characteristics with vigabatrin-associated visual field loss—could scanning laser polarimetry aid diagnosis?
暂无分享,去创建一个
[1] P. Smith,et al. Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer. , 2006, Investigative ophthalmology & visual science.
[2] G. Cavalleri,et al. Vigabatrin Retinopathy in an Irish Cohort: Lack of Correlation with Dose , 2006, Epilepsia.
[3] Hans G Lemij,et al. Diagnostic accuracy of the GDx VCC for glaucoma. , 2004, Ophthalmology.
[4] C. Westall,et al. Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children. , 2004, Ophthalmology.
[5] H. J. Choi,et al. Visual field constriction associated with vigabatrin: retinal nerve fiber layer photographic correlation , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[6] J. Sahel,et al. Vigabatrin, the GABA‐transaminase inhibitor, damages cone photoreceptors in rats , 2004 .
[7] G. Harding,et al. Examining visual field defects in the paediatric population exposed to vigabatrin , 2003, Documenta Ophthalmologica.
[8] M. Brodie,et al. Vigabatrin, but not Gabapentin or Topiramate, Produces Concentration‐related Effects on Enzymes and Intermediates of the GABA Shunt in Rat Brain and Retina , 2003, Epilepsia.
[9] S. Nightingale,et al. A controlled study of vigabatrin and visual abnormalities , 2000, The British journal of ophthalmology.
[10] J. Bruni,et al. Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy , 2000, Seizure.
[11] G. Harding,et al. Characteristics of a Unique Visual Field Defect Attributed to Vigabatrin , 1999, Epilepsia.
[12] G. Harding,et al. Visual field defects associated with vigabatrin therapy , 1999, Journal of neurology, neurosurgery, and psychiatry.
[13] P. Kertes,et al. Symptomatic and asymptomatic visual loss in patients taking vigabatrin. , 1999, Ophthalmology.
[14] T Eke,et al. Retrospective study of concussive convulsions in elite Australian rules and rugby league footballers: phenomenology, aetiology, and outcome , 1997, BMJ.
[15] H. Høgenhaven,et al. Vigabatrin in childhood epilepsy: a 5-year follow-up study. , 1995, Neuropediatrics.
[16] P. Curatolo. Vigabatrin for Refractory Partial Seizures in Children with Tuberous Sclerosis , 1994, Neuropediatrics.